# Metformin for the Treatment of Endometrial Hyperplasia

> **NCT01685762** · EARLY_PHASE1 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 18 (actual)

## Conditions studied

- Endometrial Hyperplasia
- Endometrial Hyperplasia Without Atypia

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01685762
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-10
- **Primary completion:** 2015-12-01
- **Final completion:** 2015-12-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01685762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01685762, "Metformin for the Treatment of Endometrial Hyperplasia". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01685762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*